Price movement over the last 24 hours
Align Technology, Inc. vs Oklo Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Oklo Inc trades at $48.03 (market cap $8.50B). The key difference: Align Technology, Inc. is the larger of the two by market cap, and Align Technology, Inc. is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| ALGN | OKLO | |
|---|---|---|
Market Cap | $12.86B | $8.50B |
Sector | Health | Technology |
52-Week High | $207.19 | $174.14 |
52-Week Low | $124.88 | $45.58 |
Enterprise Value | $11.92B | $6.29B |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
OKLO trades at $48.85, down 0.85% on the day, reflecting ongoing volatility as the stock remains 70% below its 52-week high. Technical indicators show a bearish trend with support at $45, while fundamentals reveal significant losses with a net income of -$105.66M in 2025. Recent news highlights progress with DOE safety approvals for its Groves reactor, but investor sentiment is mixed amid substantial cash burn and equity dilution from financing activities.
The outlook hinges on successful reactor deployment and commercialization, with analyst consensus pointing to 96% upside potential. Key risks include execution delays, regulatory hurdles, and persistent negative cash flow from operations. Long-term growth depends on converting nuclear technology advancements into revenue, making it a high-risk, high-reward opportunity for speculative investors.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →